Joydeep Goswami to serve as advisor throughJune 30 Illumina reaffirms Q1 2024 and full-year 2024 financial guidance SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that Joydeep Goswami has decided to leave Illumina. He will stay on in an advisory role through June 30 to support […]
SAN DIEGO, CALIF.- Scale Biosciences (ScaleBioTM), an innovator in single cell sequencing, today announced new appointments to its commercial team, including the appointment of new sales and support leader Kim Ferguson as Vice President of Global Sales and Support. Collectively, the appointments reflect the maturation of Scale Bio, which now offers a range of solutions […]
Advisors will support the company’s ongoing expansion of its technology for cell and gene therapy applications SAN FRANCISCO — Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced the formation of a new scientific and business advisory board composed of some of the leading minds in the industry. The board […]
Leadership change simultaneous to the Eclipse Cell Engineering platform spinout as EditCo Bio REDWOOD CITY, CA – Synthego Corporation, a leading provider of genome engineering solutions, announced that Paul Dabrowski will step down as Chief Executive Officer, effective immediately. Craig Christianson has been appointed Chief Executive Officer following an extensive search process. Mr. Dabrowski, a […]
BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a senior executive with more than 35 years of experience across life sciences, enterprise software, and technology industries, to its Board of Directors. Ms. Dowdy currently serves on the Board of Directors for SPT Labtech, a […]
LONDON and BOSTON — Synthace, the leading digital experiment platform for life science R&D, today announced the appointment of Willem Baralt as its new Chairman of the Board. Mr. Baralt joined the company in February 2024 during a period of accelerating growth, as Synthace expands its offerings. “I am thrilled to welcome Willem aboard,” said Guy Levy-Yurista, PhD, CEO of Synthace. “His addition marks […]
HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Roop K. Lakkaraju will join the company as its new Executive Vice President and Chief Financial Officer, effective April 15, 2024. Mr. Lakkaraju joins Bio-Rad from Benchmark Electronics, a multi-national leader […]
Experienced executive with extensive background as CFO for global corporations across dynamic sectors Cytek reaffirms 2024 outlook FREMONT, Calif. — Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that William (Bill) McCombe has been appointed chief financial officer of the company effective immediately. McCombe brings experience as a public company CFO at both large scale, and […]
WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax. This appointment expands the size of Repligen’s board from eight to nine members. Ms. Pax brings to Repligen over 25 years of experience leading the development and execution of growth strategies for […]
CAMBRIDGE, Mass. – Data-driven laboratory and manufacturing operational connectivity pioneer Elemental Machines announced the addition of Rob Estrella as its new SVP of Global Sales. Estrella joined Elemental Machines to support their continued and deep commitment to serving the life sciences market and growth of enterprise-level Internet of Things (IoT) technology across laboratory and manufacturing spaces. Elemental Machines is […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
